Dr. Lina Kouatly, founder and CEO of Lunatus. Image Credit: Supplied

Dubai: Tokyo headquartered Marubeni Corporation has acquired a minority stake in Lunatus Marketing & Consulting, a pharmaceutical and medical device company based out of Dubai, it was announced on Monday.

The alliance will help Marubeni bridge the Japan-Middle East markets and bring Japanese pharmaceuticals and medical devices to the Middle East. The two companies will also explore expanding their business across the other emerging markets including ASEAN and Africa.

“Marubeni is focused on the MENA market which has a large growth potential, and this transaction will enable us to expand our pharmaceutical and medical device business network from China to the Middle East and Africa. Through these efforts, we would like to reduce the healthcare disparity globally and regionally, bringing value to all patients, families and stakeholders,” said Eisuke Kamide, General Manager of Marubeni’s Healthcare & Medical Business Department.

Dr. Lina Kouatly, founder and CEO of Lunatus, said: “We are thrilled to partner with Marubeni in further consolidating and expanding our footprint as we explore unique growth opportunities regionally and into the Asian markets. This transaction presents a unique strategic opportunity to partner alongside Marubeni, a global conglomerate, in further growing the Lunatus brand.”